Webster L. Santos

Webster L. Santos

Auto-generated profile, based on publicly available information

Webster L. Santos

Department of Chemistry and VT Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in Chemical Reviews
Verified
Journal Article
Closed access
RGR. Justin Grams
R. Justin Grams
WSWebster L. Santos
Webster L. Santos
ISIon Romulus Scorei
Ion Romulus Scorei
AAAntonio Abad-García
Antonio Abad-García
CRCarol Ann Rosenblum
Carol Ann Rosenblum
Marvin A. Soriano-UrsuaMarvin A. Soriano-Ursua
Marvin A. Soriano-Ursua

7 October 2021 in Chemical Reviews
Verified
Journal Article
Closed access
SBShubhankar Kumar Bose
Shubhankar Kumar Bose
LMLujia Mao
Lujia Mao
LKLaura Kuehn
Laura Kuehn
URUdo Radius
Udo Radius
JNJan Nekvinda
Jan Nekvinda
IPIvo Piantanida
Ivo Piantanida

12 September 2018 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
DHDavid Hemming
David Hemming
RFRussell Fritzemeier
Russell Fritzemeier
SWSteve Westcott
Steve Westcott
WSWebster L. Santos
Webster L. Santos
PSPatrick Steel
Patrick Steel
The diverse applications of copper-catalyzed borylation, which has become an essential strategy in modern synthetic organic chemistry, are reviewed and illustrated.

1 April 2014 in Molecular Metabolism
Verified
Journal Article
Open access
BKBrandon M. Kenwood
Brandon M. Kenwood
JWJanelle L. Weaver
Janelle L. Weaver
ABAmandeep Bajwa
Amandeep Bajwa
Ivan PoonIvan Poon
Ivan Poon
FBFrances Byrne
Frances Byrne
Kyle HoehnKyle Hoehn
Kyle Hoehn
Dysregulation of oxidative phosphorylation is associated with increased mitochondrial reactive oxygen species production and some of the most prevalent human diseases including obesity, cancer, diabetes, neurodegeneration, and heart disease. Chemical 'mitochondrial uncouplers' are lipophilic weak acids that transport protons into the mitochondrial matrix via a pathway that is independent of ATP synthase, thereby uncoupling nutrient oxidation from ATP production. Mitochondrial uncouplers also lessen the proton motive force across the mitochondrial inner membrane and thereby increase the rate of mitochondrial respiration while decreasing production of reactive oxygen species. Thus, mitochondrial uncouplers are valuable chemical tools that enable the measurement of maximal mitochondrial respiration and they have been used therapeutically to decrease mitochondrial reactive oxygen species production. However, the most widely used protonophore uncouplers such as carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) and 2,4-dinitrophenol have off-target activity at other membranes that lead to a range of undesired effects including plasma membrane depolarization, mitochondrial inhibition, and cytotoxicity. These unwanted properties interfere with the measurement of mitochondrial function and result in a narrow therapeutic index that limits their usefulness in the clinic. To identify new mitochondrial uncouplers that lack off-target activity at the plasma membrane we screened a small molecule chemical library. Herein we report the identification and validation of a novel mitochondrial protonophore uncoupler (2-fluorophenyl){6-[(2-fluorophenyl)amino](1,2,5-oxadiazolo[3,4-e]pyrazin-5-yl)}amine, named BAM15, that does not depolarize the plasma membrane. Compared to FCCP, an uncoupler of equal potency, BAM15 treatment of cultured cells stimulates a higher maximum rate of mitochondrial respiration and is less cytotoxic. Furthermore, BAM15 is bioactive in vivo and dose-dependently protects mice from acute renal ischemic-reperfusion injury. From a technical standpoint, BAM15 represents an effective new tool that allows the study of mitochondrial function in the absence of off-target effects that can confound data interpretation. From a therapeutic perspective, BAM15-mediated protection from ischemia-reperfusion injury and its reduced toxicity will hopefully reignite interest in pharmacological uncoupling for the treatment of the myriad of diseases that are associated with altered mitochondrial function.

24 February 2006 in Science
Verified
Journal Article
Closed access
PDF file
ABAnirban Banerjee
Anirban Banerjee
WSWebster L. Santos
Webster L. Santos
GVGregory L. Verdine
Gregory L. Verdine
DNA glycosylases must interrogate millions of base pairs of undamaged DNA in order to locate and then excise one damaged nucleobase. The nature of this search process remains poorly understood. Here we report the use of disulfide cross-linking (DXL) technology to obtain structures of a bacterial DNA glycosylase, MutM, interrogating undamaged DNA. These structures, solved to 2.0 angstrom resolution, reveal the nature of the search process: The protein inserts a probe residue into the helical stack and severely buckles the target base pair, which remains intrahelical. MutM therefore actively interrogates the intact DNA helix while searching for damage.

13 July 2009 in Organic Letters
Verified
Journal Article
Closed access
MGMing Gao
Ming Gao
STSteven B. Thorpe
Steven B. Thorpe
WSWebster L. Santos
Webster L. Santos